PSA/fPSA immunoassay analysis

Monday, 01 December, 2008 | Supplied by: Olympus Australia Pty Ltd



Olympus has released PSA and fPSA assays for the Olympus AU3000i immunoassay analyser. The assays feature assay sensitivity of 0.015 µg/L. In the monitoring of patients after prostate cancer treatment, the sensitive PSA assay is suitable for the detection of recurrence of the disease.

The assays use a two-step immunometric design, minimising the risk of high-dose-hook and ensuring that the measurement of samples with elevated PSA levels will generate appropriate results. No high-dose-hook has been observed at PSA concentrations up to 160,000 µg/L, according to Olympus.

Other available test panels for the AU30001 include the primary tumour marker panel (AFP, CEA, PSA and fPSA) and the specialist tumour markers GI TN-TC and BR-TC.

 

Online: www.olympusaustralia.com.au
Phone: 03 9265 5400
Related Products

Tecan Rapid EZ DNA-Seq library preparation kit

Tecan's Rapid EZ DNA-Seq library preparation kit is designed to offer PCR-free generation of...

Air Science PCR laminar flow cabinet

The Air Science PCR laminar flow cabinet employs Air Science Multiplex HEPA filtration technology...

Bruker B.I.QUANT-UR 1.1 module for metabolite quantification in urine

Bruker's B.I.QUANT-UR 1.1 module automatically quantifies up to 150 endogenous and...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd